Europe Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029
Description
Europe Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029
Europe left ventricular device (LVAD) market is projected to register a CAGR of 9.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Europe Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Germany, France, United Kingdom, Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium, Ireland, Rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe left ventricular device (LVAD) market are:
. Scarcity of heart donors
. Increase in the number of patients suffering from heart failure
Market Players:
The key market players for Europe left ventricular device (LVAD) market are listed below:
. ABIOMED
. Abbott
. Evaheart, Inc.
. Saft
. Berlin Heart
. CorWave SA
. Jarvik Heart, Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Europe left ventricular device (LVAD) market is projected to register a CAGR of 9.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Europe Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Germany, France, United Kingdom, Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium, Ireland, Rest of Europe) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Europe left ventricular device (LVAD) market are:
. Scarcity of heart donors
. Increase in the number of patients suffering from heart failure
Market Players:
The key market players for Europe left ventricular device (LVAD) market are listed below:
. ABIOMED
. Abbott
. Evaheart, Inc.
. Saft
. Berlin Heart
. CorWave SA
. Jarvik Heart, Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
280 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Europe Left Ventricular Assist Device (Lvad) Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel
- 4.2 Porter's
- 4.3 Industrial Insights:
- 5 Europe Left Ventricular Assist Device (Lvad) Market: Regulations
- 5.1 Regulation In U.S.
- 5.1.1 Guidelines-
- 5.2 Regulation In Europe
- 5.2.1 Guidelines For The Manufacturers:
- 5.3 Regulation In Canada
- 5.3.1 Guidelines For The Manufacturers:
- 5.4 Regulation In Mexico
- 5.4.1 Guidelines For The Manufacturers:
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increasing Geriatric Population Along With Rising Prevalence Of Cardiac Diseases
- 6.1.2 Presence Of Favourable Reimbursement Policies
- 6.1.3 Changing Lifestyle Triggers The Development Of Cardiovascular Diseases
- 6.2 Restraints
- 6.2.1 High Cost Of Lvad Implantation And Treatment
- 6.2.2 Complications And Risks Associated With Lvad
- 6.3 Opportunities
- 6.3.1 Increase In Healthcare Expenditure
- 6.3.2 Increase In Minimally Invasive Procedure
- 6.3.3 Increasing Shortage Of Organ Donors
- 6.3.4 Technological Advancements In Left Ventricular Assist Devices
- 6.4 Challenges
- 6.4.1 Ongoing Covid-19
- 6.4.2 Increase In Product Recall
- 7 Europe Left Ventricular Assist Device (Lvad) Market, By Product Type
- 7.1 Overview
- 7.2 Heart Pump
- 7.3 Controller
- 7.4 Batteries
- 7.4.1 Rechargeable
- 7.4.2 Non-rechargeable
- 7.5 Wires
- 8 Europe Left Ventricular Assist Device (Lvad) Market, By Therapy
- 8.1 Overview
- 8.2 Bridge-to-transplant (Btt) Therapy
- 8.2.1 Heart Pump
- 8.2.2 Controller
- 8.2.3 Batteries
- 8.2.4 Wires
- 8.3 Destination Therapy
- 8.3.1 Heart Pump
- 8.3.2 Controller
- 8.3.3 Batteries
- 8.3.4 Wires
- 8.4 Bridge-to-candidacy (Btc) Therapy
- 8.4.1 Heart Pump
- 8.4.2 Controller
- 8.4.3 Batteries
- 8.4.4 Wires
- 8.5 Bridge-to-recovery (Btr) Therapy
- 8.5.1 Heart Pump
- 8.5.2 Controller
- 8.5.3 Batteries
- 8.5.4 Wires
- 9 Europe Left Ventricular Assist Device (Lvad) Market, By Age Group
- 9.1 Overview
- 9.2 Adult
- 9.2.1 19-39 Years
- 9.2.2 40-59 Years
- 9.2.3 60-79 Years
- 9.2.4 Above 80 Years
- 9.3 Pediatric
- 10 Europe Left Ventricular Assist Device (Lvad) Market, By Generation
- 10.1 Overview
- 10.2 Second Generation Devices
- 10.3 Third Generation Devices
- 10.4 First Generation Devices
- 11 Europe Left Ventricular Assist Device (Lvad) Market, By Design
- 11.1 Overview
- 11.2 Axial
- 11.3 Centrifugal
- 12 Europe Left Ventricular Assist Device (Lvad) Market, By Indication
- 12.1 Overview
- 12.2 Congestive Heart Failure
- 12.2.1 Heart Pump
- 12.2.2 Controller
- 12.2.3 Batteries
- 12.2.4 Wires
- 12.3 Congenital Heart Disease
- 12.3.1 Heart Pump
- 12.3.2 Controller
- 12.3.3 Batteries
- 12.3.4 Wires
- 12.4 Myocarditis
- 12.4.1 Heart Pump
- 12.4.2 Controller
- 12.4.3 Batteries
- 12.4.4 Wires
- 12.5 Cardiac Arrest
- 12.5.1 Heart Pump
- 12.5.2 Controller
- 12.5.3 Batteries
- 12.5.4 Wires
- 12.6 Familial Arrhythmias And Arrhythmic Cardiomyopathies
- 12.6.1 Heart Pump
- 12.6.2 Controller
- 12.6.3 Batteries
- 12.6.4 Wires
- 12.7 Advanced Heart Failure
- 12.7.1 Heart Pump
- 12.7.2 Controller
- 12.7.3 Batteries
- 12.7.4 Wires
- 12.8 Others
- 13 Europe Left Ventricular Assist Device (Lvad) Disease Market, By Durability
- 13.1 Overview
- 13.2 Long-term
- 13.3 Intermediate-term
- 13.4 Short-term
- 14 Europe Left Ventricular Assist Device (Lvad) Disease Market, By Pulse Type
- 14.1 Overview
- 14.2 Nonpulsatile
- 14.3 Pulsatile
- 15 Europe Left Ventricular Assist Device (Lvad) Disease Market, By End User
- 15.1 Overview
- 15.2 Hospital
- 15.3 Cardiac Cath Laboratories
- 15.4 Specialty Clinics
- 15.5 Others
- 16 Europe Left Ventricular Assist Device (Lvad) Disease Market, By Distribution Channel
- 16.1 Overview
- 16.2 Direct Tender
- 16.3 Retail Sales
- 16.4 Others
- 17 Europe Left Ventricular Assist Device (Lvad) Market, By Region
- 17.1 Europe
- 17.1.1 Germany
- 17.1.2 France
- 17.1.3 U.K.
- 17.1.4 Italy
- 17.1.5 Russia
- 17.1.6 Spain
- 17.1.7 Turkey
- 17.1.8 Netherlands
- 17.1.9 Switzerland
- 17.1.10 Belgium
- 17.1.11 Ireland
- 17.1.12 Rest Of Europe
- 18 Europe Left Ventricular Assist Device (Lvad) Market: Company Landscape
- 18.1 Company Share Analysis: Europe
- 19 Swot Analysis
- 20 Company Profile
- 20.1 Abiomed
- 20.1.1 Company Snapshot
- 20.1.2 Revenue Analysis
- 20.1.3 Company Share Analysis
- 20.1.4 Product Portfolio
- 20.1.5 Recent Developments
- 20.1.5.1 Fda Approval
- 20.1.5.2 Fda Approval
- 20.2 Abbott
- 20.2.1 Company Snapshot
- 20.2.2 Revenue Analysis
- 20.2.3 Company Share Analysis
- 20.2.4 Product Portfolio
- 20.2.5 Recent Developments
- 20.2.5.1 Supply Increment
- 20.2.5.2 Break Through Device Designation
- 20.3 Berlin Heart
- 20.3.1 Company Snapshot
- 20.3.2 Company Share Analysis
- 20.3.3 Product Portfolio
- 20.3.4 Recent Development
- 20.3.4.1 Product Approval
- 20.4 Saft (A Subsidiary Of Totalenergies)
- 20.4.1 Company Snapshot
- 20.4.2 Revenue Analysis
- 20.4.3 Company Share Analysis
- 20.4.4 Product Portfolio
- 20.4.5 Recent Development
- 20.4.5.1 Partnership
- 20.5 Jarvik Heart, Inc.
- 20.5.1 Company Snapshot
- 20.5.2 Company Share Analysis
- 20.5.3 Product Portfolio
- 20.5.4 Recent Development
- 20.5.4.1 Fda Approval
- 20.6 Corwave Sa
- 20.6.1 Company Snapshot
- 20.6.2 Product Portfolio
- 20.6.3 Recent Development
- 20.6.3.1 Expansion
- 20.7 Evaheart, Inc
- 20.7.1 Company Snapshot
- 20.7.2 Product Portfolio
- 20.7.3 Recent Development
- 20.7.3.1 Product Trial
- 21 Questionnaire
- 22 Related Reports
- List Of Figures
- Figure 1 Europe Left Ventricular Assist Device (Lvad) Market: Segmentation
- Figure 2 Europe Left Ventricular Assist Device (Lvad) Market: Data Triangulation
- Figure 3 Europe Left Ventricular Assist Device (Lvad) Market: Droc Analysis
- Figure 4 Europe Left Ventricular Assist Device (Lvad) Market: Europe Vs Regional Analysis
- Figure 5 Europe Left Ventricular Assist Device (Lvad) Market: Company Research Analysis
- Figure 6 Europe Left Ventricular Assist Device (Lvad) Market: Interview Demographics
- Figure 7 Europe Left Ventricular Assist Device (Lvad) Market: Dbmr Market Position Grid
- Figure 8 Europe Left Ventricular Assist Device (Lvad) Market: End User Coverage Grid
- Figure 9 Europe Left Ventricular Assist Device (Lvad) Market:vendor Share Analysis
- Figure 10 Europe Left Ventricular Assist Device (Lvad) Market: Segmentation
- Figure 11 Increasing Prevalence Of Cardiovascular Disease And Rising Healthcare Expenditure Are Expected To Drive The Europe Left Ventricular Assist Device (Lvad) Market In The Forecast Period Of 2022 To 2029
- Figure 12 Heart Pump Segment Is Expected To Account For The Largest Share Of The Europe Left Ventricular Assist Device (Lvad) Market In 2022 & 2029
- Figure 13 North America Is Expected To Dominate The Europe Left Ventricular Assist Device (Lvad) Market And Asia-pacific To Grow With The Highest Cagr In The Forecast Period Of 2022 To 2029
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of Europe Left Ventricular Assist Device (Lvad) Market
- Figure 15 Europe Left Ventricular Assist Device (Lvad) Market: By Product Type, 2021
- Figure 16 Europe Left Ventricular Assist Device (Lvad) Market: By Product Type, 2020-2029 (Usd Million)
- Figure 17 Europe Left Ventricular Assist Device (Lvad) Market: By Product Type, Cagr (2022-2029)
- Figure 18 Europe Left Ventricular Assist Device (Lvad) Market: By Product Type, Lifeline Curve
- Figure 19 Europe Left Ventricular Assist Device (Lvad) Market: By Therapy, 2021
- Figure 20 Europe Left Ventricular Assist Device (Lvad) Market: By Therapy, 2020-2029 (Usd Million)
- Figure 21 Europe Left Ventricular Assist Device (Lvad) Market: By Therapy, Cagr (2022-2029)
- Figure 22 Europe Left Ventricular Assist Device (Lvad) Market: By Therapy, Lifeline Curve
- Figure 23 Europe Left Ventricular Assist Device (Lvad) Market: By Age Group, 2021
- Figure 24 Europe Left Ventricular Assist Device (Lvad) Market: By Age Group, 2020-2029 (Usd Million)
- Figure 25 Europe Left Ventricular Assist Device (Lvad) Market: By Age Group, Cagr (2022-2029)
- Figure 26 Europe Left Ventricular Assist Device (Lvad) Market: By Age Group, Lifeline Curve
- Figure 27 Europe Left Ventricular Assist Device (Lvad) Market: By Generation, 2021
- Figure 28 Europe Left Ventricular Assist Device (Lvad) Market: By Generation, 2020-2029 (Usd Million)
- Figure 29 Europe Left Ventricular Assist Device (Lvad) Market: By Generation, Cagr (2022-2029)
- Figure 30 Europe Left Ventricular Assist Device (Lvad) Market: By Generation, Lifeline Curve
- Figure 31 Europe Left Ventricular Assist Device (Lvad) Market: By Design, 2021
- Figure 32 Europe Left Ventricular Assist Device (Lvad) Market: By Design, 2020-2029 (Usd Million)
- Figure 33 Europe Left Ventricular Assist Device (Lvad) Market: By Design, Cagr (2022-2029)
- Figure 34 Europe Left Ventricular Assist Device (Lvad) Market: By Design, Lifeline Curve
- Figure 35 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Indication, 2021
- Figure 36 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Indication, 2020-2029 (Usd Million)
- Figure 37 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Indication, Cagr (2022-2029)
- Figure 38 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Indication, Lifeline Curve
- Figure 39 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Durability, 2021
- Figure 40 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Durability, 2020-2029 (Usd Million)
- Figure 41 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Durability, Cagr (2022-2029)
- Figure 42 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Durability, Lifeline Curve
- Figure 43 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, 2021
- Figure 44 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, 2020-2029 (Usd Million)
- Figure 45 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, Cagr (2022-2029)
- Figure 46 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Pulse Type, Lifeline Curve
- Figure 47 Europe Left Ventricular Assist Device (Lvad) Disease Market: By End User, 2021
- Figure 48 Europe Left Ventricular Assist Device (Lvad) Disease Market: By End User, 2020-2029 (Usd Million)
- Figure 49 Europe Left Ventricular Assist Device (Lvad) Disease Market: By End User, Cagr (2022-2029)
- Figure 50 Europe Left Ventricular Assist Device (Lvad) Disease Market: By End User, Lifeline Curve
- Figure 51 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, 2021
- Figure 52 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, 2020-2029 (Usd Million)
- Figure 53 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, Cagr (2022-2029)
- Figure 54 Europe Left Ventricular Assist Device (Lvad) Disease Market: By Distribution Channel, Lifeline Curve
- Figure 55 Europe Left Ventricular Assist Device (Lvad) Market: Snapshot (2021)
- Figure 56 Europe Left Ventricular Assist Device (Lvad) Market: By Country (2021)
- Figure 57 Europe Left Ventricular Assist Device (Lvad) Market: By Country (2022 & 2029)
- Figure 58 Europe Left Ventricular Assist Device (Lvad) Market: By Country (2021 & 2029)
- Figure 59 Europe Left Ventricular Assist Device (Lvad) Market: By Product Type (2022-2029)
- Figure 60 Europe Left Ventricular Assist Device (Lvad) Market: Company Share 2021 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
